NDC 11822-8855-06 - Rite Aid Urinary Pain Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11822-8855
- Requested NDC
- 11822-8855-06
- Package NDCs from labels
- 11822-8855-6, 11822-8855-06
- Manufacturer
- Rite Aid | Reese Pharmaceutical Co
- Effective date
- 2024-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rite Aid Urinary Pain Relief - Rite Aid | Reese Pharmaceutical Co | Rite Aid | Reese Pharmaceutical Co | 2024-12-18 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11822-8855-6 | Rite Aid Urinary Pain Relief | 30 in 1 BLISTER PACK | TABLET | 30 | 5 | |
| 11822-8855-6 | Rite Aid Urinary Pain Relief | 1 in 1 CARTON | TABLET | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11822-8855 | RITE AID URINARY PAIN RELIEF (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [RITE AID] | 5 | Current NDC, Legacy NDC, 2 package rows | 20241220_d0450774-9cf0-4453-9d18-30880e125a44.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cystex Max UTI Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Clarion Brands, LLC | a4d34c20-62af-4a3c-ad2c-046ba08d1ef6 | 2026-11-09 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | 1522921b-d6c2-420d-ba0d-39ac16ba8b37 | 2026-10-30 | Adverse reactions | 0EWG668W17 |
| Cystex Max Strength UTI Pain Relief | CYSTEX MAX STRENGTH UTI PAIN RELIEF | Clarion Brands LLC | 57482f71-80d3-b20d-e063-6394a90a0cf4 | 2026-10-28 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 5dd1e5aa-df98-8482-e063-6294a90a878d | 2026-10-14 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | c1591037-62f4-469f-8bb2-a82e49dfbecf | 2026-10-12 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | 132cc592-6b03-4b75-bf39-df476fb9dc81 | 2026-10-09 | Adverse reactions | 0EWG668W17 |
| Foster and Thrive Neighbor Pharmacy Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Redpharm Drug | 5d629ecc-c737-05f6-e063-6294a90a4390 | 2026-10-09 | Warnings | 1094126 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ce702be2-eec2-4346-965e-f1f6ba342fc9 | 2026-10-09 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc | 96308f8c-66e7-486a-a5c0-ee9a133ad051 | 2026-10-09 | Warnings, Adverse reactions | 0EWG668W17 |
| Foster and Thrive Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Sportpharm LLC | 42abac37-557f-4372-b55a-12ddae71ec8b | 2026-10-06 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 49baf6e5-133a-4e1a-9740-506673d27caf | 2026-08-21 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | c0e5d32e-075f-4c76-8332-a06560001efe | 2026-08-14 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | REMEDYREPACK INC. | f6829698-b12e-484d-a322-d2f68586e637 | 2026-08-07 | Adverse reactions | 0EWG668W17 |
| Gencare-Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | Pioneer Life Sciences, LLC | 6bbf15b4-2954-40ff-8460-1ef0ed890654 | 2026-08-03 | Warnings | 0EWG668W17 |
| Nuvicare-Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | NUVICARE LLC | 5fe4e4dc-f1c4-4617-b6a6-6ea16a63abfe | 2026-08-03 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 6eb59b69-4ad0-47b1-bd3c-1d04d0852ec5 | 2026-07-27 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 56ad921f-0b6e-aa2b-e063-6394a90aec6b | 2026-07-15 | Warnings, Adverse reactions | 0EWG668W17 |
| PHENAZOPYRIDINE HYDROCHLORIDE | PHENAZOPYRIDINE HYDROCHLORIDE | Genus Lifesciences Inc. | 991b3b97-9cea-4c48-90a4-ebff55417d98 | 2026-07-14 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 7e131f69-d259-404d-a859-0497f5cbe856 | 2026-06-24 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 548edf26-c81e-f982-e063-6394a90af9da | 2026-06-18 | Warnings, Adverse reactions | 0EWG668W17 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.